New machine-learning algorithms can help optimize the next-g

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.

Related Keywords

Michigan , United States , Albertm Mattocks , Tiexin Wang , Peter Tessier , Lily Ramsey , Emily Makowski , Glaxosmithkline , Biomolecular Interaction Technology Center , National Institutes Of Health , National Science Foundation , Albertm Mattocks Professor Of Pharmaceutical Sciences , Genentech , Bristol Myers Squibb , Epivax Inc , Biointerfaces Institute , University Of Michigan , Pharmaceutical Sciences , Nature Biomedical , National Institutes , Antibody , Antibodies , Dancer , Olorectal , Colorectal Cancer , Drugs , Immune System , Machine Learning , Research ,